Post

New research · Ophthalmology
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 3d
StudyCanadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026

Bisphosphonates and glaucoma: a pharmacovigilance signal detection analysis using the FAERS database.

Yan Zhang, Yi Hong Huang, Yan Ling Xiao … Mao Sheng Guo
Read paper
OphthalmologyStudy

Alendronic acid (a bisphosphonate) is linked to more reported glaucoma cases in a safety database.

Bisphosphonates and glaucoma: a pharmacovigilance signal detection analysis using the FAERS database.

Yan Zhang … Mao Sheng Guo
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026
Purpose

To detect and characterize disproportionality signals between individual bisphosphonates and glaucoma subtypes using the U.

Methods

Data were drawn from adverse event reports from the FAERS database (Q1 2004-Q1 2025).

n = 3 cases
Results

more reports of glaucoma diagnoses among people taking alendronic acid

ROR 2.42 (95% CI 2.18 to 2.70)
null = 02.182.70
CI excludes the null - significant
More results

Subtype-level signals included alendronic acid with open-angle glaucoma (reporting odds ratio = 5.67) and normal-tension glaucoma (reporting odds ratio = 4.60); pamidronic acid with open-angle glaucoma (reporting odds ratio = 8.62); and risedronic acid with angle-closure glaucoma (reporting odds ratio = 2.93).

More results

Median time-to-onset varied from 10 days (risedronic acid) to 1579 days (pamidronic acid).

“
Conclusion · 1 of 2

This pharmacovigilance analysis identifies distinct disproportionality signals linking specific bisphosphonates to different glaucoma subtypes, with heterogeneous time-to-onset patterns.

Conclusion · 2 of 2

The findings highlight potential safety signals warranting further clinical and mechanistic investigation.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving